Public Profile

ALPS PHARMA

ALPS PHARMA, a prominent player in the pharmaceutical industry, is headquartered in Japan (JP) and operates extensively across Asia and beyond. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a diverse portfolio that includes innovative drug formulations and advanced delivery systems, ALPS PHARMA is committed to enhancing patient care through accessible medication. The company’s unique approach to research and development has led to several key milestones, solidifying its market position. Recognised for its commitment to quality and compliance, ALPS PHARMA continues to expand its reach, contributing significantly to the global healthcare landscape.

DitchCarbon Score

How does ALPS PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

4

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

ALPS PHARMA's score of 4 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

78%

ALPS PHARMA's reported carbon emissions

ALPS PHARMA, headquartered in Japan, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that ALPS PHARMA has not outlined any specific reduction targets or commitments related to climate action. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its initiatives. As the pharmaceutical industry increasingly focuses on sustainability and reducing carbon footprints, ALPS PHARMA's future commitments and actions will be crucial in aligning with global climate goals. The company may benefit from establishing clear reduction targets and engaging in industry-standard climate initiatives to enhance its environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ALPS PHARMA's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. ALPS PHARMA is headquartered in JP, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ALPS PHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Chemicals

CHEMTECHNOLOGY

US
Chemicals
Updated 10 days ago

Linde Gas AB

SE
Chemicals
Updated 3 days ago
CDP

Sinarmas Cepsa Pte. Ltd.

SG
Chemicals
Updated 1 day ago

Superior Materials, Inc

US
Chemicals
Updated 11 days ago
CDP

Hansol Chemical

KR
Chemicals
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers